Catastrophic expenditure rates and barriers for treatment adherence in patients with colorectal cancer in India: the CROCODILE study protocol

CROCODILE study group, P. A. Kingsley, J. Simoes, B. Bodhisattva, S. Chakrabortee, J. Clarke, R. Dutta, P. D. Haque, K. Jolly, R. Mittal, D. Morton, R. Oppong, A. Phillips, A. Pipara, R. K. Seenivasagam, A. Suroy, S. K. Veetil, A. Bhangu, D. Ghosh

Research output: Contribution to journalArticlepeer-review

105 Downloads (Pure)

Abstract

Aim: Little is known about the delivery of colorectal cancer treatment in India and its associated costs. The aim of this study is to identify financial and nonfinancial barriers to adherence to colorectal cancer treatment in India.

Method: CROCODILE is a mixed‐methods study with a quantitative and a qualitative workstream. The quantitative workstream will be a prospective cohort study to assess treatment adherence and catastrophic expenditure rates among patients with colorectal cancer in India. Consecutive newly diagnosed patients with histopathologically proven colorectal cancer from five tertiary hospitals in India will be included. Catastrophic expenditure will be defined as a treatment cost higher than 40% of nonsubsistence annual household income. Treatment costs will include medical, nonmedical and indirect expenses. Income assessment will be compared between three methods: patient‐reported income, the International Wealth Index and the Gapminder tool. The qualitative workstream will explore the views and experiences of colorectal cancer patients and professionals about barriers to and facilitators for treatment adherence. Individual semistructured interviews with three to five patients and cancer care professionals in each centre will be performed. An analytical framework will be developed to perform the analysis, through a combined approach (deductive and inductive). The results will be triangulated with the quantitative workstream for mutual knowledge enrichment.

Conclusion: The CROCODILE study will identify barriers to and facilitators for colorectal cancer delivery in India, influencing research and policy decisions. It will explore the feasibility of collecting data on patient‐level costs and income to inform future economic evaluations in cancer and surgical care.
Original languageEnglish
Pages (from-to)2161-2172
Number of pages12
JournalColorectal Disease
Volume23
Issue number8
Early online date13 Apr 2021
DOIs
Publication statusPublished - Aug 2021

Bibliographical note

Funding Information:
This research was funded by the National Institute for Health Research (NIHR) (NIHR 16.136.79) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK government.

India Institute Fellowship scheme for supporting this research, under the Strategic Global Engagement programme of the University of Birmingham.

Publisher Copyright:
© 2021 The Authors. Colorectal Disease published by John Wiley & Sons Ltd on behalf of Association of Coloproctology of Great Britain and Ireland.

Keywords

  • colon cancer
  • rectal cancer
  • surgery
  • surgical oncology
  • medical oncology
  • radiation oncology
  • catastrophic expenditure
  • financial catastrophe
  • treatment adherence
  • Prospective Studies
  • Humans
  • Health Expenditures
  • Colorectal Neoplasms/therapy
  • India
  • Animals
  • Alligators and Crocodiles
  • Treatment Adherence and Compliance
  • TRIAL PROTOCOL

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint

Dive into the research topics of 'Catastrophic expenditure rates and barriers for treatment adherence in patients with colorectal cancer in India: the CROCODILE study protocol'. Together they form a unique fingerprint.

Cite this